Researchers Explore Bryonia alba's Potential in Attenuating COVID-19 Pathogenesis

Strategic Insights -

Scientists at the Heritage Institute of Technology in India have been investigating the effects of ultra-diluted Bryonia alba extract on modulating HMOX-1 gene expression to counteract the pathogenesis of SARS-CoV-2. Their research, published in the Journal of Virological Methods, reveals that Bry-alb can up-regulate the HMOX-1 gene, providing a potential therapeutic approach against COVID-19.

Key Takeaways:

  • The study found that ultra-diluted Bryonia alba extract can modulate HMOX-1 gene expression to attenuate the pathogenetic effect of SARS-CoV-2 spike protein RBD antigen.
  • The study discovered that Bry-alb can up-regulate the HMOX-1 gene in diverse circumstances, suggesting a potential therapeutic approach against COVID-19.
  • The researchers used Gallus gallus domesticus eggs as a model to study the effects of Bry-alb on cytokine dysregulation caused by COVID-19.
  • The study found that IFN-a and IL-10 genes were augmented when antigen was injected and followed by administration of Bry-alb 30CH, both in therapeutic and prophylactic dose.
  • The study also found that dose-dependent variation in the expression of HMOX-1 is crucial to understand the action of the drug against SARS-CoV-2.

Statistics:

  • The study used 14th-day-old embryonated Gallus gallus domesticus eggs as a model to study the effects of Bry-alb on cytokine dysregulation caused by COVID-19.
  • The researchers used real-time PCR to detect comparative cytokine and HMOX-1 gene expressions in the eggs.
  • The study found that IFN-a and IL-10 genes were augmented by 30.4±2.5 and 25.6±2.3 times when antigen was injected and followed by administration of Bry-alb 30CH, respectively.
  • The study also found that HMOX-1 gene expression was up-regulated by 23.6±1.8 times when antigen was confronted after administration of Bry-alb 30CH.

Sources:

  • Ultra-diluted Bryonia alba extract modulates HMOX-1 gene expression to attenuate the pathogenetic effect of SARS-CoV-2 spike protein RBD antigen. Journal of Virological Methods, 2025;340:115274.
  • Heritage Institute of Technology, Dept. of Biotechnology, R&D unit, Kolkata, West Bengal 700107, India.
  • Journal of Virological Methods, Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands.
  • Pritam Goswami, Debasmita Chatterjee, Sayak Ghosh, Krishnendu Paira, and Satadal Das are the authors of the study.